Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

BACKGROUND: From earlier studies it is known that the APOE ε2/ε3/ε4 polymorphism modulates the concentrations of cerebrospinal fluid (CSF) beta-amyloid(1–42) (Aβ42) in patients with cognitive decline due to Alzheimer’s disease (AD), as well as in cognitively healthy controls. Here, in a large cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Lautner, Ronald, Insel, Philip S., Skillbäck, Tobias, Olsson, Bob, Landén, Mikael, Frisoni, Giovanni B., Herukka, Sanna-Kaisa, Hampel, Harald, Wallin, Anders, Minthon, Lennart, Hansson, Oskar, Blennow, Kaj, Mattsson, Niklas, Zetterberg, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654097/
https://www.ncbi.nlm.nih.gov/pubmed/29061195
http://dx.doi.org/10.1186/s13195-017-0313-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654097/
https://www.ncbi.nlm.nih.gov/pubmed/29061195
http://dx.doi.org/10.1186/s13195-017-0313-3

Ejemplares similares